Search Results - "Gonzalez-Angulo AM"

ASO Author Reflections: Circulating Tumor DNA as a Potential Emerging Biomarker in Malignant Phyllodes Tumors.

Authors: Rosenberger LH Reason EH Grilley-Olson JE

Source: Annals of surgical oncology [Ann Surg Oncol] 2025 Oct; Vol. 32 (11), pp. 8309-8310. Date of Electronic Publication: 2025 Aug 05.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process

Correlation of EZH2 expression and response to chemoradiation in patients with locally advanced inoperable oral cavity and oropharyngeal squamous cell cancers.

Authors: Ahmed, S. K. Soel Majumdar, Saroj Kumar Das Adhya, Amit Kumar et al.

Source: Journal of Cancer Research & Therapeutics. Dec2025, Vol. 21 Issue 7, p1391-1397. 7p.

Next-Generation Therapeutic Targets in Triple-Negative Breast Cancer.

Authors: Saleem, Kalsoom Mohammed Amirova, Mahira Firudin Rahimov, Javanshir Ali et al.

Source: European Journal of Breast Health. 2026, Vol. 22 Issue 3, p240-247. 8p.

Unlocking precision diagnostics: A multimodal framework integrating metabolomics with advanced machine learning techniques.

Authors: Shahnazari, Parisa Kavousi, Kaveh Khorshid, Hamid Reza Khorram et al.

Source: PLoS ONE. 6/15/2026, Vol. 21 Issue 6, p1-26. 26p.

Cannabidiol modulates the expression levels of circadian rhythm-related genes in breast cancer cells under normoxic and hypoxic conditions.

Authors: Ersoy, Nuray İpek, Gülnihal Çiftçi, Kezban Uçar et al.

Source: Turkish Journal of Health & Sport. Apr2026, Vol. 7 Issue 1, p6-12.

Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer.

Authors: Chung, Erika Z. Alberico, David Sannachi, Lakshmanan et al.

Source: PLoS ONE. 5/27/2026, Vol. 21 Issue 5, p1-15. 15p.

SPAG6 hypermethylation silences a novel tumor suppressor and inhibits renal cell carcinoma progression via PI3K/AKT/mTOR pathway.

Authors: Wu, Tianyu Ji, Xing Yun, Yongyang et al.

Source: PLoS ONE. 10/3/2025, Vol. 20 Issue 10, p1-21. 21p.

Zinc finger TRAF-type containing 1 can promote the progression and metastasis of lung adenocarcinoma.

Authors: Yu, Yang Zhao, Qian Song, Liang

Source: CytoJournal. 2/26/2026, Vol. 23, p1-14. 14p.

Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR Inhibition.

Authors: van der Noord, Vera E. McLaughlin, Ronan P. Karuntu, Jessica S. et al.

Source: Cellular Oncology (2211-3428). Feb2026, Vol. 49 Issue 1, p1-18. 18p.

Adaptive cohort design and LAT1 expression scale: study protocol for a Phase 2a trial of QBS72S in breast cancer brain metastases.

Authors: Taiwo, Rukayat Harary, Paul M. Trinh, Thy T. H. et al.

Source: BMC Cancer. 8/15/2025, Vol. 25 Issue 1, p1-13. 13p.

Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review.

Authors: Krasniqi, Eriseld Filomeno, Lorena Arcuri, Teresa et al.

Source: Biology Direct. 6/23/2025, Vol. 20 Issue 1, p1-19. 19p.

Multiparametric MRI–based radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer.

Authors: Mohamed, Rania M. Panthi, Bikash Adrada, Beatriz E. et al.

Source: Scientific Reports. 7/11/2024, Vol. 14 Issue 1, p1-10. 10p.

ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacy.

Authors: Liu S Chen H Gagea M et al.

Source: Cancer letters [Cancer Lett] 2025 Aug 28; Vol. 626, pp. 217775. Date of Electronic Publication: 2025 May 06.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

Theoretical investigation of AKT1 mutations in breast cancer: a computational approach to structural and functional insights.

Authors: Kamaraj, Balu C, George Priya Doss

Source: Journal of Computer-Aided Molecular Design; 5/9/2025, Vol. 39 Issue 1, p1-17, 17p

Subareolar sclerosing ductal hyperplasia shows PI3K pathway alterations.

Authors: Boyraz, Baris Robinson, Brian Lindeman, Neal et al.

Source: Histopathology. Mar2025, Vol. 86 Issue 5, p824-827. 4p.

DEPTH2 score was associated with cell proliferation and immune cell infiltrations but not with systemic treatment response in breast cancer.

Authors: Chida, Kohei Wu, Rongrong Roy, Arya Mariam et al.

Source: Scientific Reports. 11/26/2025, Vol. 15 Issue 1, p1-11. 11p.

CircRNA-14052 promotes breast cancer progression via miR-214-3p/IKBKB pathway.

Authors: Li, Donghai Zhang, Zhiying Cui, Yan et al.

Source: Hereditas. 10/3/2025, Vol. 162 Issue 1, p1-14. 14p.

Association of progesterone receptor status with breast cancer prognosis: a meta-analysis.

Authors: Hou, Yiming Li, Jianrong Zhang, Qiong et al.

Source: World Journal of Surgical Oncology. 10/2/2025, Vol. 23 Issue 1, p1-13. 13p.

Role of Radiotherapy in Elderly Patients (≥65 Years) With Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.

Authors: Sharon, Eran Snast, Igor Yerushalmi, Rinat et al.

Source: European Journal of Breast Health. Oct2025, Vol. 21 Issue 4, p285-289. 5p.

KRAS mutation promotes immune escape of lung adenocarcinoma via ZNF24/SLC7A5/PD-L1 axis.

Authors: Li, Leilei Feng, Qiang Jiang, Ya et al.

Source: BMC Cancer. 9/2/2025, Vol. 25 Issue 1, p1-20. 20p.